38 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
3 Nov 22
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:06pm
that recognize HIV epitopes in a way that differs from prior HIV vaccines.
Vir’s Commitment to COVID-19
Vir was founded with the mission of addressing
8-K
EX-99.1
VIR
Vir Biotechnology Inc
9 Aug 22
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2022 Financial Results
12:00am
to deliver on its mission of addressing serious infectious diseases, including bringing sotrovimab to appropriate patients and actively investing … engineered so that a single dose has the potential to last the entire flu season.
Vir’s Commitment to COVID-19
Vir was founded with the mission
8-K
EX-99.1
zj3x7s4fv
5 May 22
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
ijk9oe5ldojoku p24tg
25 Mar 22
Other Events
4:10pm
8-K
EX-99.2
hjvdl 4j09c13
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
3d4iro0w9h1r949
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
7a2wvpyy941 zw0vm
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
6d25z
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
8-K
EX-99.1
7o31m9bg
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
i09 wl02emb0bkr1
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
rw8k4iwql2s p2
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm